GeoVax Labs (GOVX) Net Cash Flow (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Net Cash Flow of -$1.9 million for Q4 2025, up 37.67% year-over-year from -$1.4 million in Q4 2024, and down 200.42% quarter-over-quarter from $1.9 million in Q3 2025.
GeoVax Labs (GOVX) Net Cash Flow (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Net Cash Flow for 16 consecutive years, with -$1.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Cash Flow rose 37.67% year-over-year to -$1.9 million; the TTM figure through Jun 2026 stood at -$4.4 million (down 384.11% YoY), while the FY2025 annual figure was -$2.4 million, down 156.04% from the prior year.
- Net Cash Flow declined to -$1.9 million in Q4 2025 per GOVX's latest filing, from $1.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $14.6 million in Q2 2022 and bottomed at -$7.1 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$339902.8 across 5 years, with a median of -$1.7 million in 2021.
- Annual changes were most pronounced in 2021 — Net Cash Flow soared 17909.64% — and 2025, when it tumbled 648.01%.
- GeoVax Labs' Net Cash Flow stood at -$6.7 million in 2021, then slipped by 5.7% to -$7.1 million in 2022, then grew by 11.75% to -$6.2 million in 2023, then jumped by 50.51% to -$3.1 million in 2024, then soared by 37.67% to -$1.9 million in 2025.
- Business Quant data shows GOVX's Net Cash Flow at -$1.9 million in Q4 2025, $1.9 million in Q3 2025, and -$4.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.92 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Sep 30, 2024 | 7.03 Mn |
| Sep 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 792,853.00 |
| Jun 30, 2024 | 792,853.00 |
| Mar 31, 2024 | -5.68 Mn |
| Mar 31, 2024 | -5.68 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |